Springworks Therapeutics Inc (SWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -83,187 | -258,131 | -180,834 | -127,304 | -87,385 |
| Depreciation Amortization | 1,101 | 3,468 | 2,451 | 1,573 | 729 |
| Accounts receivable | 5,891 | -40,308 | -27,042 | -18,574 | -9,599 |
| Accounts payable and accrued liabilities | 2,861 | 4,604 | 1,940 | 360 | -385 |
| Other Working Capital | -23,741 | -37,861 | -56,519 | -55,340 | -24,161 |
| Other Operating Activity | 28,316 | 152,629 | 113,905 | 78,565 | 41,871 |
| Operating Cash Flow | $-68,759 | $-175,599 | $-146,099 | $-120,720 | $-78,930 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -30 | -4,451 | -3,399 | -1,552 | -577 |
| Purchase Of Investment | 0 | -293,336 | -212,492 | -167,467 | -81,877 |
| Sale Of Investment | 73,423 | 378,582 | 277,541 | 202,021 | 103,917 |
| Purchase Sale Intangibles | N/A | -16,250 | -11,250 | -11,250 | N/A |
| Other Investing Activity | 0 | -16,250 | -11,250 | -11,250 | 0 |
| Investing Cash Flow | $73,393 | $64,545 | $50,400 | $21,752 | $21,463 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,260 | 13,201 | 12,025 | 10,235 | 5,945 |
| Common Stock Repurchased | -12,869 | -8,438 | -7,915 | -7,416 | -6,497 |
| Financing Cash Flow | $-10,609 | $4,763 | $4,110 | $2,819 | $-552 |
| Beginning Cash Position | 70,375 | 176,666 | 176,666 | 176,666 | 176,666 |
| End Cash Position | 64,400 | 70,375 | 85,077 | 80,517 | 118,647 |
| Net Cash Flow | $-5,975 | $-106,291 | $-91,589 | $-96,149 | $-58,019 |
| Free Cash Flow | |||||
| Operating Cash Flow | -68,759 | -175,599 | -146,099 | -120,720 | -78,930 |
| Capital Expenditure | -30 | -4,451 | -3,399 | -1,552 | -577 |
| Free Cash Flow | -68,789 | -180,050 | -149,498 | -122,272 | -79,507 |